The efficacy of immune checkpoint inhibitors as a part of multimodality treatment in soft tissue and bone sarcoma in an academic community setting

被引：0
|
作者：
Zarifa, Abdulrazzak [1 ]
Britto, Michele [1 ]
Brockstein, Bruce [1 ]
机构：
[1] NorthShore Univ Healthsyst, Endeavor Hlth, Evanston, IL USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23564
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Treatment practice patterns and survival among patients with metastatic soft tissue sarcoma (mSTS) in a community setting in the United States
    Chen, Clara
    Borker, Rohit
    Dhanda, Rahul
    Nadler, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [42] Alveolar soft part sarcoma from soft tissue and bone. A single reference hospital experience
    Ruz-Caracuel, I.
    de la Pena Navarro, L.
    Hernandez-Bonilla, S.
    Popescu, O. B.
    Berjon, A.
    Mendiola, M.
    Pozo Krcilinger, J. J.
    VIRCHOWS ARCHIV, 2018, 473 : S319 - S320
  • [43] Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
    Bouchereau, Sarah
    Chaplain, Louise
    Fort, Magali
    Beauchet, Alain
    Sidibe, Thomas
    Chapalain, Marie
    Gonzalez-Lara, Leire
    Longvert, Christine
    Blom, Astrid
    Saiag, Philippe
    Funck-Brentano, Elisa
    BRITISH JOURNAL OF CANCER, 2021, 125 (07) : 948 - 954
  • [44] Impact of prior treatment with immune checkpoint inhibitors on dacarbazine efficacy in metastatic melanoma
    Sarah Bouchereau
    Louise Chaplain
    Magali Fort
    Alain Beauchet
    Thomas Sidibé
    Marie Chapalain
    Leire Gonzalez-Lara
    Christine Longvert
    Astrid Blom
    Philippe Saiag
    Elisa Funck-Brentano
    British Journal of Cancer, 2021, 125 : 948 - 954
  • [45] Impact of antibiotics on the efficacy of immune checkpoint inhibitors in the treatment of primary liver cancer
    Wang, Jia-Ren
    Li, Rui-Ning
    Huang, Chao-Yi
    Hong, Chang
    Li, Qi-Mei
    Zeng, Lin
    He, Jing-Zhe
    Hu, Cheng-Yi
    Cui, Hao
    Liu, Li
    Xiao, Lu-Shan
    LIVER RESEARCH, 2022, 6 (03) : 175 - 180
  • [46] Treatment of soft tissue sarcoma cells by EGFR and/or STAT3 inhibitors
    Wang, Xiaochun
    Goldstein, David
    Crowe, Philip
    Yang, Jia-Lin
    CANCER RESEARCH, 2012, 72
  • [47] Are targeted agents the key to unlock the code for immune checkpoint inhibitors in soft-tissue sarcomas?
    Assi, Tarek
    FUTURE ONCOLOGY, 2019, 15 (28) : 3185 - 3187
  • [48] Efficacy and safety of apatinib monotherapy in advanced bone and soft tissue sarcoma: An observational study
    Zhu, Baorang
    Li, Jing
    Xie, Qiaosheng
    Diao, Liyan
    Gai, Lvhua
    Yang, Wuwei
    CANCER BIOLOGY & THERAPY, 2018, 19 (03) : 198 - 204
  • [49] The efficacy of a combination of etoposide, ifosfamide, and cisplatin in the treatment of patients with soft tissue sarcoma
    Pápai, Z
    Bodoky, G
    Szántó, J
    Poller, I
    Rahóty, P
    Eckhardt, S
    Láng, I
    Szendröi, M
    CANCER, 2000, 89 (01) : 177 - 180
  • [50] Radiation osteitis: incidence and clinical impact in the setting of radiation treatment for soft tissue sarcoma
    Vijayakumar, Gayathri
    Jones, Conor M.
    Supple, Stephen
    Meyer, John
    Blank, Alan T.
    SKELETAL RADIOLOGY, 2023, 52 (09) : 1747 - 1754
12345